Announcements Trials

Browse Landscape

Sponsor

Conditions

Keratosis, Actinic 5 Hemangioma 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Basal Cell Nevus Syndrome 1 Anemia 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 14 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Solutions × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡